Clinical Trials Logo
  1. Home
  2. Uterine Bleeding
  3. NCT03264781

The Effect of Cyclofem® for the Treatment of Irregular Uterine Bleeding in Implant Contraceptive Users

Uterine Bleeding Clinical Trial

Official title:
The Effect of Cyclofem® for the Treatment of Irregular Uterine Bleeding in Implant Contraceptive Users; a Randomized Controlled Trial

Clinical Trial Summary

The purpose of this study is to determine that once-a-month injectable contraceptive( Cyclofem® ) has the effect on treatment of irregular uterine bleeding in implant contraceptive users or not.

Clinical Trial Description

Stratified randomization Implanon and Jadelle group were done using block randomization. The participants and investigators were blinded to treatment allocation, using drug coding that not revealed until the end of study. Research assistants and nurse who did not have involve in analyses data would follow the recruitment criteria and drug injection follow the code of drug.

All participants were collected demographic data, medical history, obstetrical and gynecological history, bleeding pattern before enrollment. Then physical exam and pelvic examination were performed for all participants. Participants received single dose intramuscular injection of Cyclofem® 0.5 ml or normal saline 0.5 ml as placebo on that day of recruitment to the study. Daily record of bleeding, spotting and side effect was done on record form. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03264781
Study type Interventional
Source Chulalongkorn University
Contact Nitisa Tapanwong, MD
Phone 066817931684
Email nitisa.tapanwong@gmail.com
Status Recruiting
Phase Phase 1/Phase 2
Start date August 2016
Completion date December 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT01461824 - Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects Phase 3
Recruiting NCT05304442 - IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department Phase 3
Enrolling by invitation NCT05089721 - Questionnaire for Obstetricians and Anesthesiologist
Completed NCT01992718 - What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography Early Phase 1
Completed NCT00114088 - Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB) Phase 3
Recruiting NCT04209036 - Can 3D Laparoscopy Improve Surgical Performances in Surgeons in Training?
Recruiting NCT06219538 - DAISY Uterine Drain Device Evaluation N/A
Completed NCT03075358 - Effects of Lidocaine Spray for Reducing Pain During Endometrial Aspiration Biopsy : a Randomized Controlled Trial Phase 3
Completed NCT02705222 - Comparison Between D&C and Hysteroscopy in Management of AUB in Perimenopausal Women N/A
Completed NCT05783479 - Pharmacological Preparation of the Cervix for Hysteroscopy N/A
Recruiting NCT04766073 - Surgical Incision Closure Method to Prevent Niche Formation After Cesarean Section- Randomized Controlled Trial N/A
Not yet recruiting NCT03205111 - Role of Office Hysteroscope in Premenopausal Uterine Bleeding N/A
Active, not recruiting NCT04434066 - Outcomes on Abdominal Versus Vaginal Morcellation At Time of Hysterectomy N/A
Recruiting NCT04637022 - 4K Versus 3D Laparoscopic Colporraphy by Surgeons in Training: a Prospective Randomized Trial
Recruiting NCT06106633 - Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization N/A
Completed NCT05483348 - Clinical Predictive Factors of Success of Hysteroscopic Endometrial Ablation/Resection
Terminated NCT04676061 - Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™ Phase 4
Completed NCT04710017 - Tranexamic Acid and Depot-Medroxyprogesterone Acetate for Perimenopausal Irregular Uterine Bleeding N/A
Not yet recruiting NCT05224726 - Platelet Rich Plasma for Uterine Scar N/A
Recruiting NCT06308172 - Impact of Single- Versus Double-layer Hysterotomy Closure on Cesarean Niche Development: a Randomized Controlled Trial N/A